BioNxt Solutions (OTCMKTS:BNXTF) Posts Earnings Results

BioNxt Solutions (OTCMKTS:BNXTF) issued its quarterly earnings data on Wednesday. The company reported ($0.01) EPS for the quarter, Zacks reports.

BioNxt Solutions Stock Down 7.1%

Shares of OTCMKTS:BNXTF opened at $0.34 on Thursday. BioNxt Solutions has a 12 month low of $0.26 and a 12 month high of $0.80. The company’s fifty day simple moving average is $0.40 and its 200 day simple moving average is $0.46. The firm has a market cap of $41.51 million, a price-to-earnings ratio of -8.47 and a beta of 0.87.

BioNxt Solutions Company Profile

BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.

BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.